Adjupharm GmbH

IM Cannabis Corp. (NASDAQ:IMCC) (CSE:IMCC) announced its financial and operational results on Thursday for the year ended Dec. 2023. The Toronto-headquartered medical cannabis company with a focus on Israel and Germany reported a 10% year-over-year decrease in revenue to CA$48.8 million ($36...

Zelira Therapeutics Ltd’s (OTCQB: ZLDAF) (ASX:ZLD) insomnia medication Zenivol has achieved formal approval from German regulatory authority BfArM to launch in the German medical cannabis market. According to the company, Zenivol is the world's first and only clinically validated,...